Histamine in human breast cancer

British Journal of Surgery

Volumn 85, Issue 4, 1998, Pages 538-541

  Reynolds, J L ^a   Akhter, J A ^a   Magarey, C J ^a   Schwartz, P ^a   Adams, W J ^a   Morris, D L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE;

ARTICLE; BREAST CANCER; CANCER GRADING; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPHOCYTE FUNCTION; MAST CELL; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HISTAMINE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MAST CELLS; MIDDLE AGED;

EID: 0031924724     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1998.00625.x     Document Type: Article

References (35)

1. 2 receptors on human melanoma cells. Biochem Biophys Res Commun 1988; 151: 518-23.
2. Adams WJ, Lawson JA, Morris DL. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 1994; 35: 1632-6.
3. Brandes LJ, Beecroft WA, Hogg GR. Stimulation of in vivo tumor growth and phorbol ester-induced inflammation by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine HCl, a potent ligand for intracellular histamine receptors. Biochem Biophys Res Commun 1991; 179: 1297-304.
4. Fisher ER, Paik SM, Rockette H, Jones J, Caplan R, Fisher B. Prognostic significance of eosinophils and mast cells in rectal cancer. Hum Pathol 1989; 20: 159-63.
5. Jeziorska M, Haboubi NY, Schofield PF, Woolley DE. Mast cell distribution and tumour cell proliferation in colonic carcinoma. Gut 1993; 34(Suppl 1): S5 (Abstract).
6. Bartholeyns J, Bouclier M. Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res 1984; 44: 639-45.
7. Woolley DE, Eckley D, Tetlow LC, Whitehead RJ. Effect of mast cell products and histamine on the proliferative behaviour of human melanoma and carcinoma cells in vitro. Agents Actions 1993; 38: C182-4.
8. García-Caballero M, Núñez de Castro I, Kusche J, Vara-Thorbeck C. Histamine metabolism in human breast and colorectal cancer. Its effects on other host tissues. In: García-Caballero M, Brandes LJ, Hosoda S, eds. Histamine in Normal and Cancer Cell Proliferation. Oxford: Pergamon Press, 1993: 273-87.
9. Nielsen HJ, Kikuchi Y. Histamine-2 receptor antagonists as potential adjuvant treatment of malignant diseases. In: García-Caballero M, Brandes LJ, Hodosa S, eds. Histamine in Normal and Cancer Cell Proliferation. Oxford: Pergamon Press, 1993: 319-34.
10. 2 histamine receptors. Immunology 1980; 41: 107-14.
11. 1 antagonists reduce their proliferation and cytotoxicity. Cell Immunol 1994; 156: 212-19.
12. Berman JS, McFadden RG, Cruickshank WW, Center DM, Beer DJ. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced human lymphokines that inhibit lymphocyte migration. J Immunol 1984; 133: 1495-504.
13. Berman JS, Cruikshank WW, Center DM, Theodore AC, Beer DJ. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. Cell Immunol 1985; 95: 105-12.
14. Adams WJ, Morris DL. Cimetidine enhances lymphocyte infiltration of human colorectal cancer. Cancer 1997; 80: 15-21.
15. Adams WJ, Morris DL. Short-course cimetidine and survival with colorectal cancer. Lancet 1994; 344: 1768-9 (Letter).
16. Svendsen LB, Ross C, Knigge U, Frederiksen HJ, Graversen P, Kjaergard J et al. Cimetidine as an adjuvant treatment in colorectal cancer. A double-blind, randomized pilot study. Dis Colon Rectum 1995; 38: 514-18.
17. Matsumoto S. Cimetidine and survival with colorectal cancer. Lancet 1995; 346: 115 (Letter).
18. Morris DL, Adams WJ. Cimetidine and colorectal cancer - old drug, new use? Nature Medicine 1995; 1: 1243-4.
19. Tonnesen H, Knigge U, Bulow S, Damm P, Fischerman K, Hesselfeldt P et al. Effect of cimetidine on survival after gastric cancer. Lancet 1988; ii: 990-2.
20. Henry DP, Bowsher RR, Verburg VM. Radioenzymatic assay for histamine: development and validation. Scand J Gastroenterol 1991; 26(Suppl 180): 26-31.
21. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-77.
22. Chanda R, Ganguly AK. Diamineoxidase activity and tissue histamine content of human skin, breast and rectal carcinoma. Cancer Lett 1987; 34: 207-12.
23. García-Caballero M, Neugebauer E, Rodriguez F, Nunez de Castro I, Vara-Thorbeck C. Histamine synthesis and content in benign and malignant breast tumours. Its effects on other host tissues. Surg Oncol 1994; 3: 167-73.
24. Burtin C, Scheinmann P, Salomon JC, Lespinats G, Frayssinet C, Lebel B et al. Increased tissue histamine in tumour-bearing mice and rats. Br J Cancer 1981; 43: 684-8.
25. 1 receptor agonists, respectively. Proc Natl Acad Sci USA 1982; 79: 5052-6.
26. Khan MM, Keaney KM, Melmon KL, Clayberger C, Krensky AM. Histamine regulates the generation of human cytolytic T lymphocytes. Cell Immunol 1989; 121: 60-73.
27. Hamlin IME. Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer 1968; 22: 383-401.
28. Black MM, Barclay THC, Hankey BF. Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer 1975; 36: 2048-55.
29. Elston CW, Gresham GA, Rao GS, Zebno T, Haybittle JL, Houghton J et al. The Cancer Research Campaign (King's/ Cambridge) trial for early breast cancer clinico-pathological aspects. Br J Cancer 1982; 45: 655-69.
30. Aaltomaa S, Lipponen P, Eskelinen M, Kosma V-M, Marin S, Alhava E et al. Lymphocytic infiltrates as a prognostic variable in female breast cancer. Eur J Cancer 1992; 28A: 859-64.
31. Dawson PJ, Karrison T, Ferguson DJ. Histologic features associated with long-term survival in breast cancer. Hum Pathol 1986; 17: 1015-21.
32. 0) breast cancer. Am J Clin Pathol 1982; 78: 817-20.
33. Eremin O, Coombs RRA, Ashby J. Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity. Br J Cancer 1981; 44: 166-76.
34. Dabbous MK, Haney L, Nicolson GL, Eckley D, Woolley DE. Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NF. Br J Cancer 1991; 63: 873-8.
35. Aaltomaa S, Lipponen P, Papinaho S, Kosma V-M. Mast cells in breast cancer. Anticancer Res 1993; 13: 785-8.